Home › Funds › Dixon Mitchell Investment Counsel Inc. › GMAB
Dixon Mitchell Investment Counsel Inc. position in GMAB
GENMAB A/S · Health Care
Dixon Mitchell Investment Counsel Inc. reported holding 407,000 shares of GMAB (GENMAB A/S) in its Q3 2026 13F filing — a position valued at US$14.5M, representing 0.46% of its reported portfolio and ranking #43 among its reported holdings. Dixon Mitchell Investment Counsel Inc. has disclosed GMAB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Dixon Mitchell Investment Counsel Inc.'s GMAB position evolved
Dixon Mitchell Investment Counsel Inc. first disclosed a stake in GMAB in Q2 2026 at 416,000 shares (US$11.4M). The position peaked in Q3 2026 at 407,000 shares, worth US$14.5M. Across 2 filings, Dixon Mitchell Investment Counsel Inc. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 407,000 shares valued at US$14.5M — a reduction of -9,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 416.00K | $11.43M | New |
| Q3 2026 | 407.00K | $14.52M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GMAB and 13F data
GMAB (GENMAB A/S) is a Health Care company. 34 other funds we track also report a position in GMAB — the largest reported positions include Paradigm Biocapital Advisors LP (US$360.8M), Orbis Allan Gray Ltd (US$312.3M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$188.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMAB
- Paradigm Biocapital Advisors LP 13.13M sh · $360.77M · Q2 2026
- Orbis Allan Gray Ltd 11.37M sh · $312.28M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 6.87M sh · $188.58M · Q2 2026
- Sofinnova Investments, Inc. 4.05M sh · $111.12M · Q2 2026
- HARDING LOEVNER LP 3.09M sh · $86.90M · Q2 2026
- Deep Track Capital, LP 3.00M sh · $82.41M · Q2 2026
More on Dixon Mitchell Investment Counsel Inc.
FAQ
How long has Dixon Mitchell Investment Counsel Inc. held GMAB?
Dixon Mitchell Investment Counsel Inc. has disclosed GMAB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Dixon Mitchell Investment Counsel Inc.'s current position in GMAB?
As of Q3 2026, Dixon Mitchell Investment Counsel Inc. holds 407.00K shares of GMAB (GENMAB A/S), valued at $14.52M, representing 0.46% of its reported portfolio and ranking #43.
Has Dixon Mitchell Investment Counsel Inc. been buying or selling GMAB?
In the latest 13F filing (Q3 2026), Dixon Mitchell Investment Counsel Inc. reduced its position in GMAB. The position peaked in Q3 2026 at 407.00K shares.
Which other funds hold GMAB?
Other major institutional holders of GMAB include Paradigm Biocapital Advisors LP, Orbis Allan Gray Ltd, DEERFIELD MANAGEMENT COMPANY, L.P., among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.